Relmada Therapeutics, Inc. RLMD State And Local Income Tax Expense Benefit Continuing Operations
State And Local Income Tax Expense Benefit Continuing Operations at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations.
The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s state and local income tax expense benefit continuing operations.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s state and local income tax expense benefit continuing operations?
- Relmada Therapeutics, Inc. (RLMD) reported state and local income tax expense benefit continuing operations of $1.11K in Q4 2025.
- What does state and local income tax expense benefit continuing operations mean?
- The total income tax expense or benefit incurred at the state and local jurisdictional levels for continuing operations. It captures the tax impact of regional operations independent of federal tax obligations.